Treatment and prevention of infective endocarditis

References

• DELAHAYE F, GOULET V, LACASSIN F etal.: Characteristics of infective endocarditis in France in 1991. A 1-year survey. Eur. Heart J. (1995) 16:394–401.
   Google Scholar
• WORKING PARTY OF THE BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY: Antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. Heart (1998) 79:207–210.
   PubMed Web of Science ®Google Scholar
• WILSON WR, KARCHMER AW, DAJANI AS et al.: Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms. American Heart Association. JAMA (1995) 274:1706–1713.
   PubMed Web of Science ®Google Scholar
• RUBINSTEIN E, CARBON C: Staphylococcal endocarditis. Recommendations for therapy. Chu. Microbial Infect. (1998) 4:3S27–33.
   Google Scholar
• WILSON WR AND THE ENDOCARDITIS WORKING GROUP OF THE INTERNATIONAL SOCIETY FOR CHEMOTHERAPY: Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci and other streptococci. Chu. Microbial Infect. (1998) 4:3S17–26.
   Google Scholar
• BLATTER M, FLUCKIGER U, ENTENZA J et al.: Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Antimicrob. Agents Chemother. (1993) 37:1971–1976.
   PubMedGoogle Scholar
• FRANCIOLI P, RUCH W, STAMBOULIAN D: Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Chu. Infect. Dis. (1995) 21:1406–1410.
   PubMed Web of Science ®Google Scholar
• SEXTON DJ, TENENBAUM MJ, WILSON WR et al: Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Chu. Infect. Dis. (1998) 27:1470–1474.
   PubMed Web of Science ®Google Scholar
• WILSON AP, GAYA H: Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases. J. Antimicrob. Chemother. (1996) 38:507–521.
   PubMed Web of Science ®Google Scholar
• FRANCIOLI P, STAMBOULIAN D: Outpatient treatment of infective endocarditis. Chu. Microbial Infect. (1998) 4:3S47–55.
   Google Scholar
• FRANCIOLI P, ETIENNE J, HOIGNE R et al.: Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA (1992) 267:264–267.
   Google Scholar
• LEVINE DP, FROMM BS, REDDY BR: Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. (1991) 115:674–680.
   PubMed Web of Science ®Google Scholar
• DWORKIN RJ, LEE BL, SANDE MA, CHAMBERS HF: Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet (1989) 2:1071–1073.
   PubMed Web of Science ®Google Scholar
• CHAMBERS HF, MILLER RT, NEWMAN MD: Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann. Intern. Med. (1988) 109:619–624.
   PubMed Web of Science ®Google Scholar
• TORRES TM, DE CUETO M, VERGARA A et al.: Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cadiz. EDT. j OM. Microbial Infect. Dis. (1994) 13:559–564.
   Google Scholar
• MAINARDI JL, VANDENESCH F, CASALTA JP et al: Recommandations pour le diagnostic microbiologique et l'étude anatomopathologique des valves cardiaques au cours de l'endocardite infectieuse. Bull. Soc. Fr. 11/licrobial. (1995) 10:12–15.
   Google Scholar
• HOEN B, SELTON-SUTY C, LACASSIN F etal.: Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Chu. Infect. Dis. (1995) 20:501–506.
   Google Scholar
• RAOULT D, HOUPIKIAN P, TISSOT DH etal.: Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch. Intern. Med. (1999) 159:167–173.
   Google Scholar
• JACOBS F, ABRAMOWICZ D, VEREERSTRAETEN P et al: Brucella endocarditis: the role of combined medical and surgical treatment. Rev. Infect. Dis. (1990) 12:740–744.
   PubMedGoogle Scholar
• RAOULT D, FOURNIER PE, DRANCOURT M et al: Diagnosis of 22 new cases of Bartonella endocarditis. Ann. Intern. Med. (1996) 125:646–652.
   PubMed Web of Science ®Google Scholar
• MUSSO D, DRANCOURT M, RAOULT D: Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae. j Antimicrob. Chemother. (1995) 36:101–108.
   PubMedGoogle Scholar
• MELGAR GR, NASSER RM, GORDON SM et al.: Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital. Medicine (1997) 76:94–103.
   Google Scholar
• NGUYEN MH, NGUYEN ML, YU VL et al.: Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin. Infect. Dis. (1996) 22:262–267.
   PubMed Web of Science ®Google Scholar
• FRANCIOLI P, STAMBOULIAN D: Outpatient treatment of infective endocarditis. Clin. ll/licrobiol. Infect. (1998) 4:3S47-3S55.
   Google Scholar
• REHM SJ: Outpatient intravenous antibiotic therapy for endocarditis. Infect. Dis. Clin North Am. (1998) 12:879–901.
   PubMed Web of Science ®Google Scholar
• ZARROUK V, BOZDOGAN B, LECLERCQ R et al.: Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics. Antimicrob. Agents Chemother. (2001) 45:1244–1248.
   PubMedGoogle Scholar
• ANWER S, KEEFER MC, EVANS TG: Quinupristinidalfopristin for treatment of MRSA endocarditis refractory to conventional therapy. Infect. Dis. Pict. (1998) 7:414–416.
   Google Scholar
• LARKIN J, BUSCIGLIO L, FONTANET H et al.: Staphylococcus epidermidis endocarditis treated with RP 59500 (quinupristinidalfopristin). Clin. Infect. Dis. (1998) 26:1239–1240.
   PubMedGoogle Scholar
• DREW RH, PERFECT JR, SRINATH Let al.: Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. Antimicrob. Chemother. (2000) 46:775–784.
   Google Scholar
• AESCHLIMANN JR, ZERVOS MJ, RYBAK MJ: Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations. Antimicrob. Agents Chemother. (1998) 42:2710–2717.
   PubMedGoogle Scholar
• MATSUMURA S, SIMOR AE: Treatmentof endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/ dalfopristin, doxycycline and rifampin: a synergistic drug combination. Clin Infect. Dis. (1998) 27:1554–1556.
   PubMed Web of Science ®Google Scholar
• ORAMAS-SHIREY ME BUCHANAN LV, DILETO-FANG CL et al.: Efficacy of linezolid in a staphylococcal endocarditis rabbit model. j Antimicrob. Chemother. (2001) 47:349–352.
   PubMedGoogle Scholar
• PATEL R, ROUSE MS, PIPER KE et al: Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis. Antimicrob. Agents Chemother. (2001) 45:621–623.
   PubMedGoogle Scholar
• BABCOCK HM, RITCHIE DJ, CHRISTIANSEN E et al.: Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin. Infect. Dis. (2001) 32:1373–1375.
   PubMed Web of Science ®Google Scholar
• LEFORT A, SALEH MA, GARRY L et al: Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis. Antimicrob. Agents Chemother. (2000) 44:3017–3021.
   PubMed Web of Science ®Google Scholar
• AKINS RONDA L, RYBAK MJ: Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob. Agents Chemother. (2001) 45:454–459.
   PubMedGoogle Scholar
• BOUCHER HW, THAUVIN EC, LOEBENBERG D et al.: In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis. Antimicrob. Agents Chemother. (2001) 45:208–211.
   PubMedGoogle Scholar
• SOULI M, THAUVIN EC, ELIOPOULOS GM: In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis. Antimicrob. Agents Chemother. (2000) 44:2733–2739.
   PubMedGoogle Scholar
• MICHEL PL, VITOUX B, HAGE A etal.:Early or delayed surgery in acute native aortic valve endocarditis? In: Infective endocarditis. Horstkotte D, Bodnar E (Eds.), ICR Publishers, London (1990:220–226.
   Google Scholar
• MALQUARTI V, SARADARIAN W, ETIENNE J et al.: Prognosis of native valve endocarditis: a review of 253 cases. Eur. Heart J. (1984) 5(Suppl. C):11–20.
   Google Scholar
• TRIBOUILLOY C, RUIZ V, ROUDAUT R et al.: Devenir des abcès cardiaques paraannulaires traités médicalement: tentative d' identification des criferes de pronostic favorable. Presse Med. (1996) 25:1276–1280.
   PubMedGoogle Scholar
• TING W, SILVERMAN NA, LEVITSKY S: Valve replacement in patients with endocarditis and cerebral septic emboli. Ann. Thorac. Surg. (1991) 51:18–22.
   PubMed Web of Science ®Google Scholar
• HORSTKOTTE D, PIPER C, WIEMER M et al.: Dringlicher Herzklappenersatz nach Hirnembolie wahrend fonder. Endokarditis. Med. Klin (1998) 93:284–293.
   PubMedGoogle Scholar
• EISHI K, KAWAZOE K, KURIYAMA Y et al.: Surgical management of infective endocarditis associated with cerebral complications. Multicenter retrospective study in Japan. j Thorac. Cardiovasc. Surg. (1995) 110:1745–1755.
   PubMedGoogle Scholar
• GILLINOV AM, SHAH RV, CURTIS WE etal.: Valve replacement in patients with endocarditis and acute neurologic deficit. Ann. Thorac. Surg. (1996) 61:1125–1130.
   Google Scholar
• TING W, SILVERMAN NA, ARZOUMAN DA, LEVITSKY S: Splenic septic emboli in endocarditis. Circulation (1990) 82:IV-105-IV–109.
   Google Scholar
• LEE EM, SHAPIRO LM, WELLS FC: Conservative operation for infective endocarditis of the mitral valve. Ann. Thorac. Surg. (1998) 65:1087–1092.
   PubMedGoogle Scholar
• MICHEL PL, JUNG B, DRISSI F et al: La chirurgie mitrale conservatrice dans le traitement de f insuffisance mitrale infectieuse. Arch. Mal. Cwur (1994) 87:349–355.
   PubMedGoogle Scholar
• MUEHRCKE DD, COSGROVE III DM, LYTLE BW et al.: Is there an advantage to repairing infected mitral valves? Ann. Thorac. Surg. (1997) 63:1718–1724.
   Google Scholar
• CHAN P, OGILBY D, SEGAL B: Tricuspidvalve endocarditis. Am. Heart j (1989) 117:1140–1146.
   PubMedGoogle Scholar
• DAVID TE: Surgical management of aorticroot abscess. J Card. Surg. (1997) 12:262–269.
   PubMedGoogle Scholar
• JAULT F, GANDJBAKHCH I, CHASTRE JC etal.: Prosthetic valve endocarditis with ring abscesses. Surgical management and long-term results. I Thorac. Cardiovasc. Surg. (1993) 105:1106–1113.
   Google Scholar
• WATANACE G, HAVERICH A, SPEIER R et al.: Surgical treatment of active infective endocarditis with paravalvular involvement. j Thorac. Cardiovasc. Surg. (1994) 107:171–177.
   PubMedGoogle Scholar
• DEARANI JA, ORSZULAK TA, SCHAFF HV etal.: Results of allograft aortic valve replacement for complex endocarditis. Thorac. Cardiovasc. Surg. (1997) 113:285–291.
   Google Scholar
• DOSSCHE KM, DEFAUW JJ, ERNST SM et al.: Allograft aortic root replacement in prosthetic aortic valve endocarditis: a review of 32 patients. Ann. Thorac. Surg. (1997) 63:1644–1649.
   PubMedGoogle Scholar
• PETTERSSON G, TINGLEFF J, JOYCE FS: Treatment of aortic valve endocarditis with the Ross operation. Eur. Cardiothorac. Surg. (1998) 13:678–684.
   PubMed Web of Science ®Google Scholar
• D'UDEKEM Y, DAVID TE, FEINDEL CM et al.: Long-term results of surgery for active infective endocarditis. Eur. Cardiothorac. Surg. (1997) 11:46–52.
   PubMedGoogle Scholar
• LYTLE BW, PRIEST BP, TAYLOR PC et al.: Surgical treatment of prosthetic valve endocarditis. j Thorac. Cardiovasc. Surg. (1996) 111:198–210.
   PubMed Web of Science ®Google Scholar
• ARANKI SF, SANTINI E ADAMS DH et al.: Aortic valve endocarditis. Determinants of early survival and late morbidity. Circulation (1994) 90:11–175–11–182.
   Google Scholar
• MILON C, GARE JP, DE GEVIGNEY G et al.: L'espérance de vie des malades opérés pour endocardite infectieuse aortique a-t-elle augmenté dans les douze dernibres années? Arch. Mal. Cwur (1995) 88:1583–1591.
   Google Scholar
• MULLANY CJ, CHUA YL, SCHAFF HV et al.: Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc. (1995) 70:517–525.
   PubMedGoogle Scholar
• DAJANI AS, TAUBERT KA, WILSON W et al.: Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 96:358–366.
   Google Scholar
• DELAYE J, ETIENNE J, FERUGLIO A etal.: Prophylaxis of infective endocarditis for dental procedures. Report of a working party of the European Society of Cardiology. Eur. Heart J. (1985) 6:826–828.
   Google Scholar
• HERAUSGEGEBEN VON DER KOMMISSION FUR KLINISCHE KARDIOLOGIE DER DEUTSCHEN GESELLSCHAFT FUR HERZ- UND KREISLAUFFORSCHUNG: Empfehlungen zur Prophylaxe bakterieller Endokarditiden. Z Kardiol. (1987) 76:451–453.
   Google Scholar
• Endocarditis prophylaxis in the Netherlands. Hartbulletin (1992) 23:249–253.
   Google Scholar
• LEPORT C: Prophylaxie de fendocarditeinfectieuse. Recommandations du jury de la conference de consensus du 27 Mars 1992. Arch. Mal. Cwur (1993) 86:1897–1902.
   Google Scholar
• LEPORT C, HORSTKOTTE D, BURCKHARDT D AND THE GROUP OF EXPERTS OF THE INTERNATIONAL SOCIETY FOR CHEMOTHERAPY: Antibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus. Eur. Heart J. (1995) 16(Suppl. B):126–131.
   Google Scholar
• SCHWEIZERISCHE ARBEITSGRUPPE FUR ENDOKARDITISPROPHYLAXE: Prophylaxe der bakteriellen Endokarditis. Schweiz. Med. Wochenschr. (1984) 114:1246–1252.
   PubMedGoogle Scholar
• SIMMONS NA: Recommendations for endocarditis prophylaxis. J. Antimicrob. Chemother. (1993) 31:437–438.
   PubMedGoogle Scholar
• WORKING PARTY OF THE BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY: Antibiotic prophylaxis and infective endocarditis. Lancet (1992) 339:1292–1293.
   PubMedGoogle Scholar
• CONFERENCE DE CONSENSU DU 27 MARS 1992: Prophylaxie de l' endocardite infectieuse. Recommandations du jury. Presse Med. (1992) 21:1497–1503.
   PubMedGoogle Scholar
• DURACK DT: Prevention of infective endocarditis. N Engl. J. Med. (1995) 332:38–44.
   PubMed Web of Science ®Google Scholar
• FRANCIOLI P, GLAUSER MP: Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci. J. Infect. Dis. (1985) 152:83–89.
   PubMedGoogle Scholar
• GLAUSER MP, BERNARD JP, MOREILLON P, FRANCIOLI P: Successful single dose amoxicillin prophylaxis against experimental endocarditis: evidence for two mechanisms of protection. J. Infect. Dis. (1983) 145:568–575.
   Google Scholar
• IMPERIALE TF, HORWITZ RI: Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am. J. Med. (1990) 88:131–136.
   PubMed Web of Science ®Google Scholar
• LACASSIN F, HOEN B, LEPORT C etal.:Procedures associated with infective endocarditis in adults. A case-control study. Eur. Heart J. (1995) 16:1968–1974.
   Google Scholar
• VAN DER MEER JTM, VAN WIJK W, THOMPSON J et al: Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet (1992) 339:135–139.
   PubMedGoogle Scholar
• DURACK DT, KAPLAN EL, BISNO AL: Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry. JAMA (1983) 250:2318–2322.
   Google Scholar
• BROOKS SL: Survey of compliance with American Heart Association guidelines for prevention of bacterial endocarditis. j Am. Dent. Assoc. (1980) 101:41–43.
   PubMed Web of Science ®Google Scholar
• DOMART Y: Enquéte sur la pratique actuelle de f antibioprophylaxie de endocardite infectieuse par les dentistes. Med. Mal. Infect. (1992) 22 (Suppl.) :1092–1098.
   Google Scholar
• FORBAT LN, SKEHAN JD: Failure of provision of antibiotic prophylaxis for at risk' cardiac patients: impetus for improvement required from cardiologists. Eur. Heart J. (1993) 14:812–818.
   PubMedGoogle Scholar
• GOULD IM: Chemoprophylaxis for bacterial endocarditis. A survey of current practice in London. j Antimicrob. Chemother. (1984) 14:379–394.
   PubMed Web of Science ®Google Scholar
• HASH WAY T, STONE LJ: Antibiotic prophylaxis of subacute bacterial endocarditis for adult patients by dentists in Date County, Florida. Circulation (1982) 66:1110–1113.
   PubMedGoogle Scholar
• SADOWSKI D, KUNZEL C: Recommendations for prevention of bacterial endocarditis: compliance by dental general practitioners. Circulation (1988) 77:1316–1318.
   PubMedGoogle Scholar
• VOIRIOT P: Prophylaxie de f endocardite infectieuse. Résultat dune enquéte en 1991 auprbs de 300 médecins généralistes français. Med. Mal. Infect. (1992) 22(Suppl.):1099–1103.
   Google Scholar
• VUILLE C, BLOCH A: Les dentistes appliquent-ils correctement les recommandations pour la prophylaxie des endocardites bactériennes? Arch. Mal. Caur (1992) 85:227–232.
   PubMedGoogle Scholar
• DELAHAYE F, RIAL MO, DE GEVIGNEY G et al.: A critical appraisal of the quality of the management of infective endocarditis. J. Am. Coll Cardiol. (1999) 33:788–793.
   PubMedGoogle Scholar